Physician profile
John B Bishop
NPI 1396714713
$368.04
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.92 · 2020: $216 · 2021: $37.66 · 2022: $98.80.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $174.94 | 2020-2021 | |
| Mentor Worldwide LLC | $58.31 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $49.85 | 2019-2020 | |
| Allergan, INC. | $44.56 | 2021-2022 | |
| Misonix INC | $19.99 | 2020 | |
| Bioventus LLC | $17.41 | 2022 | |
| Ethicon US, LLC | $2.98 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bishop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.